Key terms
About XCUR
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest XCUR news
Feb 09
11:12am ET
Biotech Alert: Searches spiking for these stocks today
Feb 08
11:40am ET
Biotech Alert: Searches spiking for these stocks today
Feb 06
4:48am ET
Exicure Inc Announces Licensing Patents for Therapeutic Advancement
Feb 05
4:02pm ET
Exicure, Bluejay Therapeutics enter into patent license pact
Jan 12
11:36am ET
Biotech Alert: Searches spiking for these stocks today
Jan 11
11:25am ET
Biotech Alert: Searches spiking for these stocks today
Jan 11
11:25am ET
Biotech Alert: Searches spiking for these stocks today
Dec 11
11:06am ET
Biotech Alert: Searches spiking for these stocks today
No recent news articles are available for XCUR
No recent press releases are available for XCUR
XCUR Financials
Key terms
Ad Feedback
XCUR Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
XCUR Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range